Avacta Group Plc (FRA:RTQ1)
Germany · Delayed Price · Currency is EUR 0.6100
-0.0100 (-1.61%)
At close: Jan 23, 2026
Avacta Group Employees
Avacta Group had 151 employees as of December 31, 2024. The number of employees decreased by 3 or -1.95% compared to the previous year.
Employees
151
Change (1Y)
-3
Growth (1Y)
-1.95%
Revenue / Employee
€873
Profits / Employee
€483,667
Market Cap
260.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 151 | -3 | -1.95% |
| Dec 31, 2023 | 154 | 34 | 28.33% |
| Dec 31, 2022 | 120 | -13 | -9.77% |
| Dec 31, 2021 | 133 | 10 | 8.13% |
| Dec 31, 2020 | 123 | 4 | 3.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eleving Group | 3,671 |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 2,500 |
| SIMONA Aktiengesellschaft | 1,864 |
| Novabase S.G.P.S. | 1,281 |
| centrotherm international AG | 755 |
| Allane SE | 703 |
| ADM Hamburg Aktiengesellschaft | 509 |
| EUWAX Aktiengesellschaft | 84 |
Avacta Group News
- 11 days ago - Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION Medicine, FAP-Exatecan (AVA6103) - Wallstreet:Online
- 6 weeks ago - Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript - Seeking Alpha
- 3 months ago - Full Year 2024 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 3 months ago - Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets - Wallstreet:Online
- 3 months ago - Avacta (AIM) Reports Promising Results in Faridoxorubicin Clinical Trial - GuruFocus
- 4 months ago - Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Avacta Group Plc (AVCTF) Preliminary Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 10 months ago - Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives - GlobeNewsWire